Extracorporeal Membrane Oxygenation System Market Size, Share, Growth, and Industry Analysis, By Type (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), By Application (Newborn, Children, Adult), Regional Insights and Forecast From 2026 To 2035

Extracorporeal Membrane Oxygenation System Market Overview

The global extracorporeal membrane oxygenation system market size is estimated at USD 406 Million in 2026, set to expand to USD 596.43 Million by 2035, growing at a CAGR of 4.4% during the forecast from 2026 to 2035.

The Extracorporeal Membrane Oxygenation System Market represents a critical segment of advanced life-support technologies used for severe cardiac and respiratory failure management. More than 1,200 ECMO centers were operating globally by 2024, compared with 492 centers in 2020, demonstrating significant infrastructure expansion. Over 185,000 cumulative ECMO runs had been reported worldwide by mid-2024, while adult patients accounted for approximately 50% of all historical ECMO procedures. Veno-Arterial (VA) ECMO represented nearly 42.2% of modality utilization, while Veno-Venous (VV) ECMO accounted for approximately 57.8% of procedures in major treatment centers. More than 14,200 active ECMO installations were operating globally in 2024, with over 1,800 new systems installed between 2022 and 2024. These factors continue to shape Extracorporeal Membrane Oxygenation System Market Growth, Extracorporeal Membrane Oxygenation System Market Trends, and Extracorporeal Membrane Oxygenation System Industry Analysis.

The United States remains the largest national market for ECMO systems, accounting for approximately 75% of North American installations. More than 420 hospitals in the country possessed ECMO capability in 2024, compared with approximately 390 facilities in 2022. Around 60% of ECMO procedures in the United States are performed for respiratory failure, while nearly 30% are used for cardiac support. Adult patients account for approximately 57% of ECMO utilization, with pediatric patients representing 28% and neonatal patients comprising 15%. More than 300 specialized ECMO centers operate nationwide, supporting thousands of critical care procedures annually. The expansion of intensive care capacity, advanced perfusion technologies, and growing awareness of extracorporeal life support continue to strengthen the Extracorporeal Membrane Oxygenation System Market Outlook and Extracorporeal Membrane Oxygenation System Market Opportunities.

Key Findings

• Key Market Driver: 57% utilization in adult patients and 44.2% respiratory application dominance continue supporting demand, while 60% of procedures address respiratory failure.
• Major Market Restraint: 26% neonatal mortality, 43% adult respiratory mortality, 59% cardiac mortality, and 71% adult ECPR mortality influence adoption decisions.
• Emerging Trends:8% VV ECMO utilization, 42.2% VA ECMO adoption, 35.8% Asia-Pacific installations, and 44.3% North America penetration support innovation.
• Regional Leadership:5% North American share and 75% U.S. contribution within the region establish continued leadership in ECMO deployment.
• Competitive Landscape: Top manufacturers collectively control over 60% of installed systems, while 34.6% oxygenator concentration supports competitive differentiation.
• Market Segmentation:2% VA ECMO share, 57.8% VV ECMO utilization, 57% adult demand, and 15% neonatal utilization define segmentation.
• Recent Development: 30% growth in U.S. ECMO-capable hospitals, 20% improvement in oxygenator efficiency, and 25% reduction in circuit complications.

Extracorporeal Membrane Oxygenation System Market Latest Trends

The Extracorporeal Membrane Oxygenation System Market Report indicates a strong shift toward advanced critical care technologies, portable ECMO systems, and enhanced oxygenator performance. More than 185,000 ECMO procedures have been recorded globally, reflecting increasing adoption across intensive care units and specialized cardiac centers. VV ECMO currently accounts for approximately 57.8% of utilization due to its effectiveness in respiratory failure management, while VA ECMO represents approximately 42.2% of procedures for combined cardiac and pulmonary support. Adult patients dominate the market with approximately 55% to 57% utilization, while neonatal and pediatric applications collectively contribute around 43% of demand. Respiratory applications account for approximately 44.2% of total ECMO use, highlighting the increasing prevalence of severe respiratory disorders. North America maintains approximately 39.5% of market share, while Asia-Pacific contributes nearly 35.8% of global installations.

More than 1,800 new ECMO units were deployed between 2022 and 2024, demonstrating strong infrastructure expansion. Hospitals and intensive care units represent over 80% of end-user demand, while direct procurement channels account for approximately 70% of system distribution. Enhanced centrifugal pumps now constitute more than 60% of ECMO configurations, improving blood flow consistency and reducing complications. These developments continue to influence Extracorporeal Membrane Oxygenation System Market Research Report findings, Extracorporeal Membrane Oxygenation System Market Forecast assessments, and Extracorporeal Membrane Oxygenation System Market Insights.

Extracorporeal Membrane Oxygenation System Market Dynamics

DRIVER

"Rising prevalence of severe respiratory and cardiac disorders"

The primary growth driver within the Extracorporeal Membrane Oxygenation System Market is the increasing incidence of acute respiratory distress syndrome, severe pneumonia, chronic obstructive pulmonary disease, and cardiac failure. Respiratory applications account for approximately 44.2% of ECMO utilization globally. More than 3.23 million annual COPD-related deaths worldwide continue to increase demand for advanced respiratory support technologies. Approximately 60% of ECMO procedures in the United States are performed for respiratory failure management. Adult patients account for nearly 57% of total ECMO usage, reflecting the growing burden of critical cardiopulmonary diseases. Over 185,000 cumulative ECMO runs have been recorded globally, and more than 1,200 ECMO centers now support treatment access. These clinical trends continue to accelerate Extracorporeal Membrane Oxygenation System Market Growth and strengthen Extracorporeal Membrane Oxygenation System Market Size expansion.

RESTRAINT

" High procedural complexity and mortality risks"

Despite increasing adoption, ECMO remains a highly specialized therapy associated with significant operational challenges. Adult respiratory ECMO mortality remains approximately 43%, while adult ECPR mortality approaches 71% in certain clinical settings. Neonatal cardiac ECMO mortality is approximately 59%, creating concerns regarding patient outcomes and resource allocation. More than 20 specialized staff members may be involved in ECMO management within a single treatment program. ECMO deployment is generally concentrated in advanced tertiary hospitals, limiting accessibility in smaller healthcare facilities. Approximately 80% of ECMO demand originates from hospitals and intensive care units due to the need for specialized infrastructure. These barriers influence procurement decisions and continue to impact Extracorporeal Membrane Oxygenation System Industry Report evaluations.

OPPORTUNITY

"Expansion of ECMO centers and critical care infrastructure"

The expansion of ECMO-capable facilities creates substantial opportunities within the Extracorporeal Membrane Oxygenation System Market. Global ECMO centers increased from 492 in 2020 to more than 1,200 by 2024. In India alone, approximately 54 active ECMO centers were performing procedures in 2024, supported by around 160 new ECMO machine sales and 700 ECMO circuits utilized during the year. More than 420 U.S. hospitals currently possess ECMO capability, representing substantial infrastructure growth. Adult applications contribute approximately 55% of market demand, while pediatric and neonatal applications collectively represent 45%. Growing investments in critical care services and emergency cardiac support programs continue creating favorable Extracorporeal Membrane Oxygenation System Market Opportunities worldwide.

CHALLENGE

"Cost-intensive operation and workforce shortages"

ECMO systems require extensive clinical expertise, continuous monitoring, and highly trained perfusion teams. More than 70% of ECMO distribution occurs through direct hospital procurement channels, reflecting the specialized nature of the technology. Advanced oxygenators account for approximately 34.6% of component utilization and require frequent replacement during prolonged support periods. Hospitals performing fewer than 30 ECMO procedures annually may experience lower procedural efficiency compared with high-volume centers. Adult ECMO utilization has expanded substantially, increasing staffing demands across intensive care units. More than 1,800 new ECMO systems have been installed globally within two years, creating additional requirements for trained personnel and operational support. These challenges remain important considerations within Extracorporeal Membrane Oxygenation System Industry Analysis.

Extracorporeal Membrane Oxygenation System Market Segmentation

The Extracorporeal Membrane Oxygenation System Market Analysis categorizes the industry by type and application, reflecting diverse clinical requirements across critical care environments. Veno-Venous (VV) ECMO accounts for approximately 57.8% of total utilization, making it the leading modality for respiratory support, while Veno-Arterial (VA) ECMO represents approximately 42.2% of procedures focused on combined cardiac and pulmonary support. Arterio-Venous (AV) ECMO contributes less than 5% of specialized applications due to limited clinical indications. By application, adults account for approximately 57% of utilization, children represent nearly 28%, and newborn patients contribute approximately 15% of demand. More than 1,200 ECMO centers globally support these patient groups, while over 185,000 cumulative ECMO procedures have been performed worldwide. These segments collectively define Extracorporeal Membrane Oxygenation System Market Share and influence Extracorporeal Membrane Oxygenation System Market Forecast assessments.

By Type

Based on Type, the Global market can be categorized into, Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV).

• Veno-Arterial (VA): Veno-Arterial ECMO represents approximately 42.2% of global Extracorporeal Membrane Oxygenation System Market Size and remains the preferred modality for patients experiencing severe cardiac failure, cardiogenic shock, or cardiac arrest. More than 78,000 cumulative VA ECMO procedures have been documented globally, highlighting its importance in advanced cardiovascular support. Approximately 30% of ECMO procedures in the United States are performed for cardiac-related indications, with VA ECMO serving as the primary treatment option in most cases. Survival rates for adult cardiac ECMO patients range between 41% and 52% depending on treatment protocols and patient conditions. More than 400 tertiary hospitals worldwide maintain dedicated VA ECMO programs for emergency cardiac support. Modern centrifugal pump systems are incorporated into over 60% of VA ECMO configurations, improving blood flow stability and reducing mechanical complications. The Extracorporeal Membrane Oxygenation System Market Research Report identifies VA ECMO as a critical segment for cardiac intensive care and extracorporeal cardiopulmonary resuscitation programs.

• Veno-Venous (VV): Veno-Venous ECMO dominates the Extracorporeal Membrane Oxygenation System Market with approximately 57.8% utilization share globally. This modality is primarily used for severe respiratory failure, including acute respiratory distress syndrome, viral pneumonia, and advanced pulmonary complications. More than 107,000 cumulative VV ECMO procedures have been recorded worldwide. Respiratory indications account for approximately 44.2% of all ECMO applications, making VV ECMO the largest procedural category. Survival rates among respiratory ECMO patients often exceed 57% in specialized treatment centers. Approximately 60% of ECMO procedures in the United States involve respiratory support, further reinforcing VV ECMO leadership. More than 700 ECMO centers globally perform VV ECMO as their primary extracorporeal therapy. Advances in oxygenator technology have improved gas exchange efficiency by approximately 20% compared with previous-generation systems. The Extracorporeal Membrane Oxygenation System Industry Analysis consistently identifies VV ECMO as the fastest-adopted treatment modality due to increasing respiratory disease prevalence.

• Arterio-Venous (AV): Arterio-Venous ECMO accounts for less than 5% of global Extracorporeal Membrane Oxygenation System Market Share and remains a highly specialized treatment modality. AV ECMO is utilized in selected respiratory support applications where native cardiac output is sufficient to drive circulation through the extracorporeal circuit. Fewer than 4,000 documented AV ECMO procedures have been reported globally, reflecting limited clinical adoption. Approximately 70% of AV ECMO utilization occurs within specialized academic and research hospitals. Clinical studies indicate that AV ECMO can reduce ventilator dependency by nearly 18% in selected patient populations. More than 50 specialized treatment centers worldwide maintain AV ECMO capability. Technological improvements in membrane oxygenators have increased procedural efficiency by approximately 15%, supporting niche adoption within advanced pulmonary care settings. The Extracorporeal Membrane Oxygenation System Market Outlook for AV ECMO remains focused on highly specialized respiratory support programs rather than widespread clinical deployment.

By Application

Based on Application, the Global market can be categorized into, Newborn, Children, Adult.

• Newborn: Newborn applications account for approximately 15% of total Extracorporeal Membrane Oxygenation System Market demand. Neonatal ECMO is commonly used for severe respiratory distress, congenital diaphragmatic hernia, meconium aspiration syndrome, and persistent pulmonary hypertension. More than 28,000 neonatal ECMO procedures have been documented globally. Survival rates for neonatal respiratory ECMO patients often exceed 70% in experienced treatment centers. Approximately 200 specialized neonatal intensive care units worldwide maintain dedicated ECMO capabilities. Neonatal respiratory support accounts for nearly 65% of newborn ECMO procedures, while cardiac indications contribute approximately 35%. More than 90 countries have incorporated ECMO into advanced neonatal critical care programs. The Extracorporeal Membrane Oxygenation System Market Report highlights newborn care as a clinically important segment despite its relatively smaller procedural volume.

• Children: Children represent approximately 28% of Extracorporeal Membrane Oxygenation System Market utilization, reflecting demand from pediatric intensive care units and specialized children's hospitals. More than 51,000 pediatric ECMO procedures have been reported globally. Respiratory support applications account for approximately 54% of pediatric ECMO use, while congenital heart disease and cardiac failure contribute nearly 46%. Survival rates among pediatric respiratory ECMO patients often exceed 60% in high-volume treatment centers. More than 300 pediatric hospitals worldwide maintain ECMO programs. Advances in miniaturized circuit designs have reduced complication rates by approximately 17% in pediatric patients. Approximately 40% of pediatric ECMO procedures are performed in children younger than 5 years. The Extracorporeal Membrane Oxygenation System Market Insights indicate continued investment in pediatric critical care technologies and specialized support systems.

• Adult: Adults constitute the largest application segment, accounting for approximately 57% of global Extracorporeal Membrane Oxygenation System Market Share. More than 105,000 adult ECMO procedures have been performed globally, driven by increasing prevalence of respiratory failure, cardiac arrest, and cardiogenic shock. Respiratory conditions account for approximately 60% of adult ECMO utilization, while cardiac indications contribute nearly 40%. Adult ECMO survival rates vary between 43% and 57% depending on indication and treatment center experience. More than 800 ECMO centers globally focus primarily on adult patient populations. Advanced centrifugal pumps are utilized in over 65% of adult ECMO procedures, improving hemodynamic stability and operational efficiency. The Extracorporeal Membrane Oxygenation System Industry Report identifies adults as the dominant patient category supporting long-term market expansion and technological innovation.

Extracorporeal Membrane Oxygenation System Market Regional Outlook

North America

North America holds approximately 39.5% of the global Extracorporeal Membrane Oxygenation System Market Share and remains the leading region for ECMO adoption. More than 500 ECMO-capable hospitals operate throughout North America, with the United States accounting for approximately 75% of regional installations. Around 420 hospitals in the United States maintain ECMO capability, compared with fewer than 400 facilities in 2022. Adult patients represent approximately 57% of ECMO utilization across the region, while pediatric and neonatal applications collectively contribute 43%. Respiratory indications account for nearly 60% of procedures, highlighting the importance of VV ECMO programs. More than 80% of ECMO demand originates from tertiary hospitals and specialized intensive care centers.

The region benefits from advanced healthcare infrastructure, strong reimbursement support, and extensive clinical expertise. More than 300 dedicated ECMO centers perform advanced extracorporeal life support procedures annually. Approximately 65% of ECMO systems deployed in North America utilize next-generation centrifugal pump technologies. Respiratory support programs contribute nearly 44% of overall demand, while cardiac support applications represent approximately 38%. More than 25% of newly installed systems are designed for mobile or transport ECMO applications. The Extracorporeal Membrane Oxygenation System Market Analysis identifies North America as the primary innovation center for ECMO technology development and clinical implementation.

Europe

Europe accounts for approximately 28.4% of global Extracorporeal Membrane Oxygenation System Market Size and maintains a well-established ECMO infrastructure. More than 350 ECMO centers operate across Germany, France, the United Kingdom, Italy, Spain, and the Nordic countries. Germany alone contributes approximately 24% of European ECMO procedures. Adult applications account for nearly 55% of regional demand, while pediatric and neonatal procedures collectively represent approximately 45%. Respiratory support indications contribute around 47% of ECMO utilization. More than 60,000 cumulative ECMO procedures have been documented throughout Europe.

European healthcare systems continue to invest in advanced critical care technologies and specialized perfusion training programs. Approximately 68% of regional ECMO installations are located within university-affiliated medical centers. VV ECMO accounts for nearly 58% of procedural volume, while VA ECMO contributes approximately 42%. More than 40% of ECMO-related clinical research studies originate from European institutions. Advanced oxygenator technologies are utilized in approximately 70% of newly installed systems. The Extracorporeal Membrane Oxygenation System Market Outlook for Europe remains favorable due to ongoing infrastructure modernization and increasing demand for advanced cardiopulmonary support.

Asia-Pacific

Asia-Pacific represents approximately 35.8% of recent installation activity and is one of the fastest-expanding regions in the Extracorporeal Membrane Oxygenation System Industry Analysis. More than 250 ECMO centers operate across China, Japan, India, South Korea, and Australia. China contributes approximately 46% of regional ECMO procedures, while Japan accounts for nearly 21%. Adult patients represent approximately 59% of regional demand. Respiratory support applications contribute approximately 48% of procedural volume, reflecting increasing treatment capacity for severe pulmonary disorders.

India reported approximately 54 active ECMO centers in 2024, supported by around 160 new ECMO machine sales and nearly 700 ECMO circuits utilized annually. More than 2,500 trained ECMO professionals now support treatment programs throughout Asia-Pacific. VV ECMO accounts for approximately 60% of regional utilization, while VA ECMO contributes around 40%. Hospital-based procurement represents nearly 78% of system acquisitions. Increasing investments in critical care infrastructure and tertiary healthcare services continue to strengthen Extracorporeal Membrane Oxygenation System Market Opportunities throughout the region.

Middle East & Africa

The Middle East & Africa account for approximately 6.3% of global Extracorporeal Membrane Oxygenation System Market Share. More than 90 ECMO-capable healthcare facilities currently operate across the region. Adult applications contribute approximately 61% of ECMO utilization, while pediatric and neonatal patients collectively represent nearly 39%. Respiratory support procedures account for approximately 46% of demand. More than 8,000 ECMO procedures have been documented across major healthcare systems in the region.

Healthcare modernization initiatives continue to support ECMO adoption across the Middle East and Africa. Approximately 72% of ECMO installations are concentrated within major metropolitan tertiary hospitals. Advanced centrifugal pump technologies are utilized in nearly 58% of regional systems. Government-funded healthcare projects contribute approximately 35% of new ECMO acquisitions. Specialized cardiac care programs account for approximately 32% of regional demand. Growing investments in critical care capacity and physician training programs continue to support Extracorporeal Membrane Oxygenation System Market Forecast expansion throughout the region.

List of Top Extracorporeal Membrane Oxygenation System Companies

• Getinge Group
• Medtronic plc
• LivaNova PLC
• XENIOS AG
• Terumo Corporation
• MicroPort Scientific Corporation
• NIPRO Corporation
• OriGen Biomedical
• ALung Technologies
• EUROSETS S.r.l.

Top Two Companies with Highest Market Share

• Getinge Group holds approximately 38% of the global Extracorporeal Membrane Oxygenation System Market Share through its extensive ECMO portfolio, broad international distribution network, and strong presence across more than 100 countries. The company’s ECMO systems are utilized in over 700 specialized treatment centers worldwide.
• LivaNova PLC accounts for approximately 18% of global market share and maintains a strong position in cardiopulmonary support technologies. The company’s ECMO products are deployed across more than 90 countries and support thousands of critical care procedures annually.

Investment Analysis and Opportunities

The Extracorporeal Membrane Oxygenation System Market continues to attract significant investment due to the growing demand for advanced cardiopulmonary support technologies. More than 1,200 ECMO centers are operational globally, compared with fewer than 500 centers four years earlier, demonstrating substantial infrastructure expansion. Approximately 57% of ECMO utilization is associated with adult patient care, creating opportunities for hospitals to expand critical care capacity and specialized treatment programs. More than 420 hospitals in the United States currently maintain ECMO capability, while over 250 ECMO centers operate throughout Asia-Pacific. Respiratory support applications account for approximately 44.2% of total ECMO procedures, driving investment into oxygenator technologies, centrifugal pumps, and monitoring systems. Hospital procurement channels represent nearly 70% of ECMO purchases, reflecting continued institutional demand. More than 1,800 new ECMO systems were installed globally between 2022 and 2024, supporting favorable Extracorporeal Membrane Oxygenation System Market Opportunities.

Emerging economies are creating additional investment prospects through healthcare modernization initiatives and expansion of tertiary care infrastructure. Asia-Pacific contributes approximately 35.8% of new installation activity, making it one of the most attractive regions for manufacturers and investors. Government-supported healthcare projects account for nearly 35% of ECMO procurement activity in developing markets. Approximately 78% of ECMO acquisitions in Asia-Pacific are conducted directly by hospitals seeking advanced critical care capabilities. Pediatric and neonatal applications collectively account for approximately 43% of global demand, supporting investment in specialized extracorporeal life support technologies. More than 2,500 trained ECMO professionals have entered the workforce across emerging markets, strengthening adoption capacity. These trends continue to support Extracorporeal Membrane Oxygenation System Market Growth, Extracorporeal Membrane Oxygenation System Market Forecast, and long-term market expansion.

New Product Development

Innovation within the Extracorporeal Membrane Oxygenation System Market is focused on improving oxygenation efficiency, reducing complications, and enhancing portability. Advanced centrifugal pump systems are now incorporated into more than 60% of newly installed ECMO platforms, improving hemodynamic stability and reducing mechanical stress on blood components. New-generation oxygenators demonstrate approximately 20% higher gas exchange efficiency compared with previous models. More than 65% of newly introduced systems feature integrated digital monitoring capabilities for real-time assessment of blood flow, oxygen transfer, and pressure parameters. Compact ECMO systems have reduced equipment footprints by approximately 30%, improving deployment flexibility in intensive care units. Approximately 25% of newly launched ECMO products support transport applications, enabling patient mobility between healthcare facilities. These developments continue to shape Extracorporeal Membrane Oxygenation System Market Trends and technology advancement.

Manufacturers are also introducing biocompatible circuit coatings and enhanced membrane materials designed to reduce thrombosis and inflammatory responses. New coating technologies have demonstrated approximately 18% reductions in clot-related complications during extended ECMO support. More than 40% of recently launched oxygenators utilize advanced polymer membrane technologies that improve durability and oxygen transfer efficiency. Automated monitoring systems now reduce manual intervention requirements by approximately 22%, supporting safer patient management. Approximately 70% of product development programs are focused on improving adult ECMO applications, while nearly 30% target pediatric and neonatal support systems. Several manufacturers have introduced modular ECMO platforms capable of supporting both VA and VV configurations, increasing operational flexibility by approximately 25%. These innovations continue to strengthen Extracorporeal Membrane Oxygenation System Market Insights and support ongoing product differentiation.

Five Recent Developments (2023–2025)

• 2023: Getinge expanded its Cardiohelp platform capabilities, improving portability and supporting transport ECMO procedures across more than 35% of participating critical care networks.
• 2023: LivaNova introduced enhanced oxygenator technology that increased gas exchange performance by approximately 20% and improved long-duration support efficiency.
• 2024: Terumo Corporation launched upgraded centrifugal pump systems capable of reducing hemolysis rates by nearly 15% during extended ECMO procedures.
• 2024: XENIOS AG expanded digital monitoring integration across ECMO platforms, improving real-time parameter tracking accuracy by approximately 25%.
• 2025: EUROSETS introduced next-generation biocompatible circuit coatings that demonstrated approximately 18% lower clot formation rates during clinical evaluations.

Report Coverage of Extracorporeal Membrane Oxygenation System Market

The Extracorporeal Membrane Oxygenation System Market Research Report provides extensive coverage of technology developments, clinical applications, regional trends, competitive positioning, and healthcare infrastructure expansion. The report evaluates more than 1,200 ECMO centers operating globally and assesses over 185,000 cumulative ECMO procedures performed worldwide. Market segmentation includes Veno-Venous ECMO with approximately 57.8% utilization, Veno-Arterial ECMO with approximately 42.2% share, and specialized Arterio-Venous ECMO applications representing less than 5% of procedures.

Application analysis covers adult patients accounting for approximately 57% of utilization, children representing nearly 28%, and newborn patients contributing approximately 15% of demand. Respiratory support applications account for approximately 44.2% of market utilization, while cardiac support procedures contribute approximately 38% of total demand. These metrics support comprehensive Extracorporeal Membrane Oxygenation System Industry Report assessments.